PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
about
Nanotechnology-based drug delivery systems for treatment of oral cancer: a reviewPolymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.The current state of head and neck cancer gene therapy.Polymeric drug delivery systems for intraoral site-specific chemoprevention of oral cancer.Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.The prophylactic effect of Acetobacter syzygii probiotic species against squamous cell carcinoma.
P2860
PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
@en
type
label
PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
@en
prefLabel
PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
@en
P2093
Anxun Wang
Dongsheng Yu
Hongzhang Huang
Yiyang Chen
P2860
P304
P356
10.2217/17435889.3.6.813
P577
2008-12-01T00:00:00Z